The US Food and Drug Administration has expanded the emergency use authorization for Pfizer's COVID-19 vaccine to include people ages 12 to 15.
Search / 5 results found Showing: 5 of 5
If you've gotten the Pfizer COVID-19 vaccine, you'll likely need a third dose within a year.
Pfizer on Friday asked the FDA for an amendment to its emergency use authorization of its COVID-19 vaccine to expand its use in people ages 12-15 in the United States.
The first children have been vaccinated in Moderna's Phase 2/3 pediatric COVID-19 vaccine trial, the company announced Tuesday in a statement.
A new report published in the New England Journal of Medicine on Wednesday suggests that Pfizer-BioNTech's COVID-19 vaccine can protect people against concerning new coronavirus variants, including one first seen in South Africa called B.1.351.